Medical qualification of a commercial spaceflight participant: Not your average astronaut

Aviation Space and Environmental Medicine

Volumn 77, Issue 5, 2006, Pages 475-484

  Jennings, Richard T ^a   Murphy, David M F ^a   Ware, David L ^a   Aunon, Serena M ^a   Moon, Richard E ^a   Bogomolov, Valery V ^a   Morgun, Valeri V ^a   Voronkov, Yuri I ^a   Fife, Caroline E ^a   Boyars, Michael C ^a   Ernst, Randy D ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Emphysema; Pleurodesis; Pneumothorax; Spaceflight; Ventricular ectopy

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALAN SR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; GLUCOCORTICOID; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; SPIRIVA HANDIHALER; TIOTROPIUM BROMIDE; VERAPAMIL;

ADULT; AGE; ALTITUDE; ARTICLE; BLOOD GAS ANALYSIS; CASE REPORT; CENTRIFUGE; CERTIFICATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COSMONAUT; ETHICS; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG EMPHYSEMA; LUNG FUNCTION; MALE; MEDIASTINUM MASS; MEDICAL ASSESSMENT; MICROGRAVITY; PLEURODESIS; RISK ASSESSMENT; SAFETY; SPACE FLIGHT; SPONTANEOUS PNEUMOTHORAX; STANDARD; SUPRAVENTRICULAR PREMATURE BEAT; THORACOSCOPY; TOURISM;

AEROSPACE MEDICINE; ATELECTASIS; CYSTS; EXERCISE TEST; HUMANS; KIDNEY DISEASES; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MONITORING, AMBULATORY; PHYSICAL EXAMINATION; PLEURODESIS; PNEUMOTHORAX; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RESPIRATORY FUNCTION TESTS; SPACE FLIGHT; THORACIC SURGERY, VIDEO-ASSISTED; VENTRICULAR PREMATURE COMPLEXES;

STREPTOCOCCUS PNEUMONIAE;

EID: 33646487126     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Ahmed Z, Shrager JB. Mediastinal talcoma masquerading as a thymoma. Ann Thorac Surg 2003; 75:568-9.
2. American Society of Aerospace Medicine Specialists (ASAMS). Clinical practice guidelines for chronic obstructive pulmonary disease. Alexandria, VA: Aerospace Medical Association; 2001. Retrieved November 2005 from: http://www.asams.org/guidelines/Completed/New%20COPD.htm.
3. Baumann MH, Strange C. Treatment of pneumothorax: a more aggressive approach? Chest 1997; 112:789-804.
4. Berg BW, Dillard TA, Derderian SS, Rajagopal KR. Hemodynamic effects of altitude exposure and oxygen administration in chronic obstructive pulmonary disease. Am J Med 1993; 94:407-12.
5. Boon HK, Aquino SL, Fischman AJ. Flurodeoxyglucose positron emission tomography and CT after talc pleurodesis. Chest 2004; 125:2356-60.
6. Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial [published erratum appears in Lancet 2003; 361:1660]. Lancet 2003; 361:449-56.
7. Combivent Inhalation Aerosol Study Group. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. Chest 1994; 105:1411-9.
8. Combivent Inhalation Aerosol Study Group. Routine nebulized ipratropium and albuterol together are better than either alone in COPD. Chest 1997; 112:1514-21.
9. Dulchavsky SA, Schwarz KL, Kirkpatrick AW, et al. Prospective evaluation of thoracic ultrasound in the detection of pneumothorax. J Trauma 2001; 50:201-5.
10. Everett WD. Spontaneous pneumothorax: an analysis of pleurectomy vs conservative therapy in United States Air Force fliers. Aviat Space Environ Med 1988; 59:1089-93.
11. Fuchs HS. Idiopathic spontaneous pneumothorax and flying. With particular reference to the etiological role of decreased atmospheric pressure, pressure breathing, increased gravitational forces, and anti-G-suit action. Aerosp Med 1967; 38:1283-5.
12. Fuchs HS. Incidence of spontaneous pneumothorax in apparently health aircrews. Aerosp Med 1967; 38:1286-8.
13. rd ed. Philadelphia: Lippincott Williams and Wilkins; 2002:328-9.
14. Hakomaki J, Keski-Nisula L, Paakkala T. Contrast enhancement of round atelectasis. Acta Radiologica 2002; 43:376-9.
15. Hanania NA, Darken P, Horstman D, et al. The efficacy and safety of fluticasone propionate (250 mcg)/salmeterol (50 mcg) combined in the Diskus inhaler for the treatment of COPD. Chest 2003; 124:834-43.
16. Hopkirk JAC, Pullen MJ, Fraser JR. Pleurodesis: the results of treatment for spontaneous pneumothorax in the Royal Air Force. Aviat Space Environ Med 1983; 54:158-60.
17. Johnson AOC. Chronic obstructive pulmonary disease: fitness to fly with COPD. Thorax 2003; 58:729-32.
18. Kennedy, L, Harley RA, Sahn SA, et al. Talc slurry pleurodesis. Chest 1995; 107:1707-12.
19. Kennedy L, Sahn SA. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 1994; 106:1215-22.
20. Lategola MT, Flux M, Lyne PJ. Altitude tolerance of general pilots with normal or partially impaired spirometric function. Aviat Space Environ Med 1978; 49:1123-5.
21. Lategola MT, Flux M, Lyne PJ. Spirometric assessment of potential respiratory impairment in general aviation. Aviat Space Environ Med 1977; 48:508-11.
22. Light RW, O'Hara VS, Moritz TE, et al. Intrapleural tetracycline for prevention of recurrent spontaneous pneumothorax. Results of a Department of Veterans Affairs cooperative study. JAMA 1990; 264:2224-30.
23. Lyseng-Williamson KA, Keating GM. Inhaled salmeterol/fluticasone propionate combination in chronic obstructive pulmonary disease. Am J Respir Med 2002; 1:273-82.
24. 18F]fluoro-2-deoxy-d-glucose PET. J Comput Assist Tomogr 1998; 22:601-4.
25. Mellem H, Emhjellen S, Horgen O. Pulmonary barotrauma and arterial gas embolism caused by an emphysematous bulla in a SCUBA diver. Aviat Space Environ Med 1990; 61:559-62.
26. Menzies R, Faser R. Round atelectasis: pathologic and pathogenic features. Am J Surg Pathol 1987; 11:674-81.
27. Mitlehner W, Friedrich M, Dissmann W. Value of computer tomography in the detection of bullae and blebs in patients with primary spontaneous pneumothorax. Respiration 1992; 59:221-7.
28. Moreno LA, Wolbrink AM. An airman with alpha-1 antitrypsin deficiency. Federal Air Surgeon's Medical Bulletin. Washington, DC: Federal Aviation Administration; summer 2002.
29. Nannini L, Lasserson TJ, Poole P. Combined corticosteroid and long acting beta-agonist in home inhaler for chronic obstructive pulmonary disease. In: The Cochrane Library, issue 1. Chichester, UK: John Wiley and Sons, Ltd.; 2004.
30. Negro DWR, Pomari C, Tognella S, et al. Salmeterol and fluticasone 50 microgram/250 microgram bid in combination provides a better long-term control than salmeterol 50 microgram bid alone and placebo in COPD patients already treated with theophylline. Pulm Pharmacol Ther 2003; 16:241-6.
31. North JH. Thorascopic management of spontaneous pneumothorax allows prompt return to aviation duties. Aviat Space Environ Med 1994; 65:1128-9.
32. O'Donovan PB, Schenk M, Kaiser L, et al. Evaluation of the reliability of computed tomographic criteria used in the diagnosis of round atelectasis. J Thoracic Imaging 1997; 12:54-8.
33. Pauwels RA, Buist AS, Ma P, et al. GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-76.
34. Pickard JS. Pneumothorax. AFPAM-48-132, 2000. Available at http://www.brooks.af.mil/web/consult_service/waiver%20guide/Pulmonary/ Pneumothorax.htm
35. Prisk GK. The lung in space. Clin Chest Med 2005; 26:415-38.
36. Rabe KF. State of the art in beta2-agonist therapy: a safety review of long acting agents. Int J Clin Pract 2003; 57:689-97.
37. rd ed. New York: Castle Connolly; 2000:24-7.
38. Robb DJ. Cases from the aerospace medicine residents' teaching file. Case #57: spontaneous pneumothorax. Aviat Space Environ Med 1994; 65:170-2.
39. Rogge JD, Meyer JF, Brown WK. Comparison of the incidence of cardiac arrythmias during +Gx acceleration, treadmill exercise and tilt table testing. Aerosp Med 1969; 40:1-5.
40. Sawin CF, Taylor GR, Smith WL, eds. Extended duration orbiter medical project: final report 1989-1995. DSOs 463 and 602. Houston, TX: Lyndon B. Johnson Space Center; 1999:1-2 through 1-4. NASA/SP-1999-534.
41. Tashkin DP, Cooper CB. The role of long-acting bronchodilators in the management of stable COPD. Chest 2004; 125:249-59.
42. Tomashefski JF, et al. Effects of altitude on emphysematous blebs. Aerosp Med 1966; 1158-62.
43. Torphy DE, Leverett SD, Lamb LE. Cardiac arrhythmias occurring during acceleration. Aerosp Med 1966; 37:52.
44. Voge VM, Anthracite R. Spontaneous pneumothorax in the USAF aircrew population: a retrospective study. Aviat Space Environ Med 1986; 57:939-49.
45. Weiss N, Solomon SB. Talc pleurodesis mimics pleural metastasis: differentiation with positron emission tomography/computed tomography. Clin Nucl Med 2003; 28:811-4.
46. Yim AP, Liu HP. Video assisted thoracoscopic management of primary spontaneous pneumothorax. Surg Laparosc Endosc 1997; 7:236-40.